Eli Lilly's 340B claims data deadline passes, sparking potential new dispute
read at Endpoints ↗RegulatoryNeutral
Eli Lilly set a deadline for hospitals to submit 340B drug‑pricing program claims data under its new policy.
The deadline has now passed, and the company has not indicated what actions it will take next.
Industry observers say the lack of response could spark a fresh dispute over how the 340B program is administered.
The situation highlights ongoing tensions between drug makers and hospitals regarding data transparency and pricing discounts.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Eli Lilly's claims data deadline may kick off new 340B fight”
read at Endpoints ↗82 words · retrieved Jun 9
comments(0)
5-min edit window · permanent after that